MucoLife Therapeutics, a Swedish biotech company developing pioneering drugs for Chronic obstructive pulmonary disease (COPD), announces a partnership with the US-based life science accelerator Health Wildcatters. Out of nearly 700 applications, MucoLife Therapeutics was one of ten startups chosen to participate in the Health Wildcatters program.
Read More